How to design multi-target drugs: Target search options in cellular networks
arXiv:q-bio/0703010
Abstract
Despite improved rational drug design and a remarkable progress in genomic, proteomic and high-throughput screening methods, the number of novel, single-target drugs fell much behind expectations during the past decade. Multi-target drugs multiply the number of pharmacologically relevant target molecules by introducing a set of indirect, network-dependent effects. Parallel with this the low-affinity binding of multi-target drugs eases the constraints of druggability, and significantly increases the size of the druggable proteome. These effects tremendously expand the number of potential drug targets, and will introduce novel classes of multi-target drugs with smaller side effects and toxicity. Here we review the recent progress in this field, compare possible network attack strategies, and propose several methods to find target-sets for multi-target drugs.
12 pages, 3 figures, 1 table
References in corpus (5)
- Uncovering the overlapping community structure of complex networks in nature and society
- The efficiency of multi-target drugs: the network approach might help drug design
- Some protein interaction data do not exhibit power law statistics
- Stress-induced rearrangements of cellular networks: consequences for protection and drug design
- Aging cellular networks: chaperones as major participants